ADAR1 Capital Management »

Immunovant shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $33M 1.1M 28.51
2024-06-30 $13M 477k 26.40
2024-03-31 $2.0M 61k 32.31
2023-12-31 $5.7M 134k 42.13

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Deep Track Capital
Armistice Capital
T. Rowe Price Investment Management
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant